Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study

Volume: 54, Issue: 3, Pages: 288 - 297
Published: Dec 8, 2019
Abstract
Objective: Previous randomised, double-blind, placebo-controlled studies have shown that Kava (a South Pacific medicinal plant) reduced anxiety during short-term administration. The objective of this randomised, double-blind, placebo-controlled study was to perform a larger, longer-term trial assessing the efficacy and safety of Kava in the treatment of generalised anxiety disorder and to determine whether gamma-aminobutyric acid transporter...
Paper Details
Title
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Published Date
Dec 8, 2019
Volume
54
Issue
3
Pages
288 - 297
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.